Showing results (1201-1210 of 1,322) with videos related to
Sort By:
Pageof 133
Gynecologic Oncology|August 7, 2018
Molecular-integrated risk profile to determine adjuvant radiotherapy in endometrial cancer: Evaluation of the pilot phase of the PORTEC-4a trialB G Wortman, T Bosse, R A Nout, et al.European Journal of Cancer (Oxford, England : 1990)|December 20, 2011
Five-year quality of life of endometrial cancer patients treated in the randomised Post Operative Radiation Therapy in Endometrial Cancer (PORTEC-2) trial and comparison with norm dataRemi A Nout, Hein Putter, Ina M Jürgenliemk-Schulz, et al.Blood|January 6, 2017
TCR-based therapy for multiple myeloma and other B-cell malignancies targeting intracellular transcription factor BOB1Lorenz Jahn, Pleun Hombrink, Renate S Hagedoorn, et al.Nature Genetics|June 20, 2024
Non-stem cell lineages as an alternative origin of intestinal tumorigenesis in the context of inflammationMathijs P Verhagen, Rosalie Joosten, Mark Schmitt, et al.The Journal of Clinical Endocrinology and Metabolism|August 11, 2015
Metabolic Health in Short Children Born Small for Gestational Age Treated With Growth Hormone and Gonadotropin-Releasing Hormone Analog: Results of a Randomized, Dose-Response TrialManouk van der Steen, Annemieke J Lem, Danielle C M van der Kaay, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 18, 2009
First-in-man prospective evaluation of temporal changes in coronary plaque composition by in vivo intravascular ultrasound radiofrequency data analysis: an Integrated Biomarker and Imaging Study (IBIS) substudyGastón A Rodriguez-Granillo, Patrick W Serruys, Eugène P McFadden, et al.International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|July 14, 2012
Long-term survival data of triple modality treatment of stage IIB-III-IVA cervical cancer with the combination of radiotherapy, chemotherapy and hyperthermia - an updateAnneke Westermann, Olav Mella, Jacoba Van Der Zee, et al.Schizophrenia Research|April 2, 2019
Recovery from daily-life stressors in early and chronic psychosisThomas Vaessen, Wolfgang Viechtbauer, Yori van der Steen, et al.The New England Journal of Medicine|June 12, 2009
Duration of androgen suppression in the treatment of prostate cancerMichel Bolla, Theodorus M de Reijke, Geertjan Van Tienhoven, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|August 9, 2021
A broad and systematic approach to identify B cell malignancy-targeting TCRs for multi-antigen-based T cell therapyMiranda H Meeuwsen, Anne K Wouters, Lorenz Jahn, et al.Pageof 133